MeiraGTx Holdings plc (NASDAQ: MGTX) is a Healthcare company (Biotechnology) with a market capitalization of $827M. The Maz Rating grades it against the other companies in its sector.
MeiraGTx Holdings plc's current Maz Rating and its five factor grades are for members: log in to see them.
At $8.46, MeiraGTx Holdings plc trades at 9.9x trailing earnings, 2.1x sales and 3.8x book value, with an EV/EBITDA of 3.0. Over the last twelve months it generated about $402M of revenue and $83M of net income. It runs a gross margin of 95.7%, an operating margin of 44.8% and a net margin of 19.5%. It shows return on equity of 85.4%, return on invested capital of 48.0% and a free cash flow yield of -1.1%. On the balance sheet: a debt-to-equity ratio of 0.62 and a current ratio of 4.62. Over the past 52 weeks the share price ranged from $6.62 to $15.35, with a beta of 1.35.
MeiraGTx Holdings plc does not currently pay a dividend.
7 Wall Street analyst ratings cover the stock: 7 Buy, for a Buy consensus. This is the sell side's view, separate from the Maz Rating.
Figures are trailing twelve months unless stated. The Maz Rating and Maz Dividend Score rank a company against its own sector; they are not price targets or recommendations.